Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027

The global dual specificity tyrosine phosphorylation regulated kinase 1A market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dual-specificity tyrosine phosphorylation-regulated kinase 1A or DYRK1A is a eukaryotic serine-threonine protein kinase that belongs to the CMGC group and contributes to the development of several human malignancies and cognitive deficits that are observed in down syndrome and Alzheimer's disease. The major factor accelerating the growth of the market is the increasing prevalence of Alzheimer's disease across the globe.

To Request a Sample of our Report on Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market: https://www.omrglobal.com/request-sample/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-market

According to the Alzheimer's Association, more than 6 million Americans of all ages have Alzheimer's. Additionally, in 2021, an estimated 6.2 million Americans age 65 and older are living with Alzheimer's dementia out of which 72% are aged 75 or older. Furthermore, as per the same source, one in nine people age 65 and older or 11.3% has Alzheimer's dementia. Moreover, almost two-thirds of Americans with Alzheimer's are women. Apart from this, the number of people aged 65 and older with Alzheimer's dementia is estimated to grow to 12.7 million by 2050. Hence, the increasing Alzheimer's disease is resulting increased prevalence of cognitive deficits and human malignancies which in turn is driving the growth of the market.

Some major players operating in the market include Pharmasum Therapeutics AS, Carna Biosciences Inc., and NeuroNascent Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Brickell Biotech, Inc. announced that it has entered into a definitive agreement with Voronoi Inc. The agreement was aimed to grant Brickell exclusive, global rights to research, develop and commercialize novel therapeutics generated from a proprietary DYRK1A inhibitor platform.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

• By Type

• By Application

Regions Covered-

• North America

• Europe

• Asia-Pacific

• Rest of the World

Competitive Landscape- Pharmasum Therapeutics AS, Carna Biosciences Inc., and NeuroNascent Inc., among others.

(Get 15% Discount on Buying this Report)[mj1]

A full Report of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market is Available @ https://www.omrglobal.com/industry-reports/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-market

Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Report by Segment

By Type

• PST-900

• NNI-351

• FX-9847

• Others

By Application

• Colon Cancer

• Down Syndrome

• Lung Cancer

• Pancreatic Cancer

• Others

Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.